Gravity, skeletal muscle, and ectopic steatosis: a new framework for insulin resistance in diabetic liver and pancreatic disease.

Insulin resistance is important in the cause of type 2 diabetes mellitus (T2DM), but traditional markers for obesity are not enough to explain metabolic risk. The idea for this review stems from an interest in understanding the interplay between ectopic fat accumulation and activity of skeletal muscle with gravitational loading in precipitating insulin resistance and a 'Gravity-Muscle-Ectopic Fat Axis' as an integrative framework. We conducted a literature search using a narrative review approach in PubMed, Scopus, Web of Science, and Google Scholar. We identified and screened published studies from 2018 to 2026 and synthesized up to 40 high-quality, representative articles. We critically analyzed the evidence on ectopic fat, Skeletal Muscle Metabolism, anti-gravity muscle activity, Exercise interventions, and glucose homeostasis. Ectopic deposition of fat in skeletal muscle, pancreas, and liver is thought to be associated with insulin resistance and impaired pancreatic β-cell function. Ectopic fat and insulin sensitivity are tightly linked, and metabolic health is closely tied to both. Skeletal muscle has emerged as a key regulator of glucose homeostasis, and emerging evidence suggests that gravitational loading and anti-gravity muscle activation may contribute to more favorable ectopic fat distribution and improved metabolic regulation. This Gravity-Muscle-Ectopic Fat Axis offers a new conceptual model that connects muscle activity, ectopic fat loss, and insulin sensitivity. Addressing muscle health and ectopic fat may be promising strategies for preventing and treating insulin resistance (IR) and T2DM.